Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy

Grzmil, Michal; Seebacher, Jan; Hess, Daniel; Behe, Martin; Schibli, Roger; Moncayo, Gerald; Frank, Stephan; Hemmings, Brian A.

doi:10.1016/j.cellsig.2016.06.005

Metadata only

Author

Date

2016-09

Type

Journal Article

Citations

Cited null times in Web of Science

ETH Bibliography

yes

Altmetrics

Publication status

published

External links

https://doi.org/10.1016/j.cellsig.2016.06.005

Journal / series

Cellular Signalling

Volume

28(9)

Pages / Article No.

1412 - 1421

Publisher

Elsevier

Subject

MNK; eIF4E; eIF4G; Glioma; MTC; Temozolomide

Organisational unit

03688 - Schibli, Roger / Schibli, Roger

Notes

Received 12 May 2016, Revised 7 June 2016, Accepted 7 June 2016, Published online 8 June 2016.

More

Show all metadata

Citations

Cited null times in Web of Science

ETH Bibliography

yes

Altmetrics

Research Collection

Search

Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy Mendeley CSV RIS BibTeX

Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy

Mendeley

CSV

RIS

BibTeX